Menu Search
Equities

Ventas Inc

VTR*:MEX

Ventas Inc

Actions
  • Price (MXN)1,287.79
  • Today's Change0.00 / 0.00%
  • Shares traded160.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Nov 04 2024 11:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Ventas, Inc. is a real estate investment trust (REIT). The Company’s portfolio includes senior housing communities, which provide valuable services to residents. The Company leverages its operational expertise and data-driven insights from its Ventas Operational Insights platform. The Company has approximately 1,351 properties in North America and the United Kingdom. Its portfolio also includes outpatient medical buildings, research centers and healthcare facilities. The Company, through its Senior Housing Operating Portfolio segment, invests in senior housing communities. Through its Outpatient Medical and Research Portfolio segment, it primarily acquires, owns, develops, leases, and manages outpatient medical buildings and research centers. Through its Triple-Net Leased Properties segment, it invests in and owns senior housing communities, skilled nursing facilities, long-term acute care facilities, freestanding inpatient rehabilitation facilities and other healthcare facilities.

  • Revenue in USD (TTM)4.80bn
  • Net income in USD-66.50m
  • Incorporated1987
  • Employees486.00
  • Location
    Ventas IncSUITE 3300, 353 N. CLARK STREETCHICAGO 60654United StatesUSA
  • Phone+1 (312) 660-3800
  • Fax+1 (302) 655-5049
  • Websitehttps://www.ventasreit.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.